Search


FDA Philippines: Draft Guidelines for Registration of Chemical and Biological Pharmaceutical Products
The Food and Drug Administration (FDA) of the Philippines has recently published draft guidelines to streamline the registration process...
Sharan Murugan
Feb 222 min read
18 views
0 comments


USFDA Statement: New Patient Medication Information - Medication Guide for Patients
Yesterday (31 May 2023) the United States Food & Drug Administration's Center for Drug Evaluation and Research (CDER) proposed a new...
Sharan Murugan
Jun 1, 20231 min read
30 views
0 comments


EMA Guidance: Good Practice Guide for the use of the Metadata Catalogue of Real-World Data Sources
Earlier today (27-September-2022) EMA released draft guidance on the "Good Practice Guide for the use of the Metadata Catalogue of...
Sharan Murugan
Sep 27, 20221 min read
53 views
0 comments


USFDA: Office of New Drugs Research Program & Guidance - Software Assurance for Production & Quality
Yesterday (13-September,2022) FDA published a new webpage to share the most recent research activities of the Center for Drug Evaluation...
Sharan Murugan
Sep 14, 20222 min read
8 views
0 comments


USFDA Guidance: Changes to Disposable Manufacturing Materials, Clinical Pharmacology Considerations
Multiple guidances were updated and released by the USFDA last week and had some important updates related to Drugs, Biologics, and...
Sharan Murugan
Jul 31, 20222 min read
18 views
0 comments


India CDSCO Guidance: 3 IVD Draft Guidances for Consultation
Recently the Indian Central Drugs Standard Control Organization (CDSCO) released three draft guidance documents, where the In vitro...
Sharan Murugan
Jul 27, 20221 min read
47 views
0 comments


Malaysia’s - DRAFT GUIDANCE DOCUMENT LICENSING FOR ESTABLISHMENT
Malaysia’s Medical Device Authority (MDA) & Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) has updated guidance updates...
Sharan Murugan
Jun 16, 20221 min read
18 views
0 comments


USFDA's Guidance on Risk Management Plans to Mitigate Drug Shortages
The USFDA recently released draft guidance intended to help stakeholders develop, maintain, and implement risk management plans (RMPs) to...
Sharan Murugan
May 22, 20221 min read
17 views
0 comments


USFDA Guidance on Product Quality Assessments - Benefit-Risk Considerations
Earlier on 9-May-2022, FDA announced that a draft guidance document was available to assist the industry regarding the Benefit-Risk...
Sharan Murugan
May 11, 20221 min read
25 views
0 comments


Cybersecurity of Legacy Medical Devices - Guidance-IMDRF
The International Medical Device Regulators Forum (IMDRF) Medical Device Cybersecurity Guide (MDCG) Working Group Proposed document...
Sharan Murugan
May 11, 20221 min read
13 views
0 comments


USFDA: Activities and Engagement with the Voluntary Improvement Program
The FDA’s Center for Devices and Radiological Health (CDRH) is issuing this draft guidance to describe its policy regarding FDA’s...
Sharan Murugan
May 8, 20221 min read
7 views
0 comments


Guidance on Classification of Rehabilitation Medical Devices -Malaysia’s MDA
Malaysia's Medical Device Authority (MDA) has drafted a guidance that will assist manufacturers and authorized representatives to...
Sharan Murugan
May 2, 20221 min read
17 views
0 comments


Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price - Philippines FDA
The Philippines' Food and Drug Administration (FDA) is seeking feedback on draft guideline aimed at streamlining the process of changing...
Sharan Murugan
May 2, 20221 min read
37 views
0 comments


Pakistan (DRAP) Draft Guidelines on FP Labeling & Packaging and BA-BE Guidelines
Finished Product Labeling and Packaging Guidelines To provide guidance on how to make sure the information on labels and package leaflets...
Sharan Murugan
Apr 24, 20221 min read
116 views
0 comments


Malaysia’s MDA- Draft Medical Device Labeling Guidance
The Medical Device Authority (MDA) of Malaysia is seeking feedback on draft regulations for medical device labeling. The MDA's fifth...
Sharan Murugan
Apr 24, 20221 min read
9 views
0 comments


FDA's Considerations for Waiver Requests for pH Adjusters in Generic Drug Products
On April 13, 2022, FDA published new draft guidance for the industry entitled “Considerations for Waiver Requests for pH Adjusters in...
Sharan Murugan
Apr 17, 20221 min read
29 views
0 comments


Draft Guidleline on Change Notification For Registered Medical Device-Malaysia’s MDA
This Guidance Document was prepared by the Medical Device Authority (MDA) to help the industry and healthcare professionals in their...
Sharan Murugan
Apr 17, 20221 min read
11 views
0 comments


FDA's Draft Guidance on Cybersecurity in MD: Quality System Consideration & Content of Premarket Sub
This draft guidance document is being distributed for comment purposes only. Cybersecurity incidents have rendered medical devices and...
Sharan Murugan
Apr 10, 20221 min read
13 views
0 comments


EMA Draft Guidance- How To Approach the Protection Clinical Trial Information System (CTIS)
On 7 April 2022, European Medicines Agency released a draft guidance document on how to approach the protection of personal data and...
Sharan Murugan
Apr 10, 20222 min read
177 views
0 comments


ICH-Draft Guideline on Pediatric Extrapolation & FInal Guidance on Considerations for Clinical Study
As part of its recent announcement, the International Council for Harmonization (ICH) released on 4 April 2022, a draft E11A guideline...
Sharan Murugan
Apr 10, 20222 min read
13 views
0 comments